Single nucleotide polymorphisms of CYP3A5, but not of other genes, influence the exposure to tacrolimus in paediatric renal transplant recipients: A pharmacogenetic substudy of the TWIST study

被引：0
|
作者：
Feneberg, R.
Billing, H. [1 ]
Hoecker, B. [1 ]
van Damme-Lombaerts, R. [1 ,2 ]
Friman, S. [3 ]
Jaray, J. [4 ]
Vondrak, K. [5 ]
Sarvary, E. [4 ]
Dello Strologo, L. [6 ]
Armstrong, V. W. [7 ]
Oellerich, M. [7 ]
Toenshoff, B. [1 ]
Toenshoff, B. [1 ]
van Ahsen, N. [8 ]
机构：
[1] Univ Childrens Hosp Heidelberg, Div Pediat Nephrol, Heidelberg, Germany
[2] Univ Hosp Gasthuisberg, Louvain, Belgium
[3] Univ Gothenburg, Gothenburg, Sweden
[4] Univ Budapest, Budapest, Hungary
[5] Prague Agr Univ, Prague, Czech Republic
[6] IRCCS, Osped Bambino Gesu, Rome, Italy
[7] Univ Gottingen, Gottingen, Germany
[8] Univ Gottingen, Dept Clin Chem, Gottingen, Germany
来源：
PEDIATRIC NEPHROLOGY | 2009年 / 24卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：910 / 910
页数：1
相关论文
共 50 条
  • [21] THE EFFECT OF CYP3A5 POLYMORPHISMS ON LONG TERM TACROLIMUS DISPOSITION IN RENAL RECIPIENTS
    Imperiali, Nora C.
    Larriba, Julian M.
    Groppa, Silvia R.
    Giordani, Maria C.
    Maule, Gabriel B.
    Mombelli, Cesar A.
    Bratti, Griselda I.
    Argibay, Pablo F.
    Algranati, Salomon L.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 81 - 81
  • [22] THE EFFECT OF CYP3A4 AND CYP3A5 POLYMORPHISMS ON THE TACROLIMUS PLASMA CONCENTRATION IN CHINESE POST RENAL TRANSPLANT RECIPIENTS
    Wen, Gaiyan
    Yuan, Hong
    Xi, Lanyan
    Huang, Zhijun
    Li, Ying
    Lu, Yao
    JOURNAL OF HYPERTENSION, 2016, 34 : E300 - E300
  • [23] Population Pharmacokinetic of Tacrolimus in Tunisian Renal Transplant Patients: Influence of CYP34A and CYP3A5 Polymorphisms
    Ben-Fredj, N.
    Hannachi, I.
    Chadli, Z.
    Kerkeni, E.
    Ben-Romadhane, H.
    Ben-Fadhel, N.
    Hammouda, M.
    Boughattas, N. A.
    Chaabane, A.
    Aouam, K.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2019, 33 : 74 - 74
  • [24] AN EFFECT OF DONOR-RECIPIENT CYP3A5 GENOTYPE COMBINATION ON TACROLIMUS EXPOSURE IN RENAL TRANSPLANT RECIPIENTS
    Warzyszynska, Karola
    Karpeta, Edyta
    Kosieradzki, Maciej
    TRANSPLANT INTERNATIONAL, 2021, 34 : 257 - 257
  • [25] Influence of CYP3A5 and MDR1(ABCB1) Polymorphisms on the Pharmacokinetics of Tacrolimus in Chinese Renal Transplant Recipients
    Rong, G.
    Jing, L.
    Deng-Qing, L.
    Hong-Shan, Z.
    Shai-Hong, Z.
    Xin-Min, N.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (09) : 3455 - 3458
  • [26] Effects of CYP3A5 Genetic Polymorphism on the Pharmacokinetics of Tacrolimus in Renal Transplant Recipients
    Mac Guad, R.
    Zaharan, N. L.
    Chik, Z.
    Mohamed, Z.
    Peng, N. K.
    Adnan, W. A. H. W. M.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (01) : 81 - 87
  • [27] Influence of CYP3A4, CYP3A5 and MDR-1 polymorphisms on tacrolimus pharmacokinetics and early renal dysfunction in liver transplant recipients
    Shi, Yunying
    Li, Yi
    Tang, Jiangtao
    Zhang, Junlong
    Zou, Yuangao
    Cai, Bei
    Wang, Lanlan
    GENE, 2013, 512 (02) : 226 - 231
  • [28] CYP3A5 Polymorphisms Leading to Tacrolimus Toxicity Following an Adult Renal Transplant
    Alotaibi, Nouf
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2023, 34 (03) : 250 - 253
  • [29] CYP3A5 polymorphisms and their effects on tacrolimus exposure in an ethnically diverse South African renal transplant population
    Muller, W. K.
    Dandara, C.
    Manning, K.
    Mhandire, D.
    Ensor, J.
    Barday, Z.
    Freercks, R.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2020, 110 (02): : 159 - 166
  • [30] INFLUENCE OF CYP3A5 GENOTYPE ON THE PHARMACOKINETIC PROFILE OF TACROLIMUS IN PAEDIATRIC TRANSPLANT PATIENTS
    McLean, K.
    Fung, A.
    Gijsen, V.
    Nalli, N.
    Safi, M.
    Daljevic, T.
    Ogaki, C.
    Mital, S.
    CANADIAN JOURNAL OF CARDIOLOGY, 2012, 28 (05) : S291 - S291
12345